{"schema_version":"secwatch.filing_event.v1","accession":"0001585364-26-000143","form_type":"8-K","ticker":"PRGO","cik":"0001585364","company_name":"PERRIGO Co plc","filed_at":"2026-08-05T10:37:49+00:00","discovered_at":"2026-08-05T10:40:00.170211+00:00","generated_at":"2026-08-05T10:40:07.804942+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Perrigo Q2 2026 Core adj. EPS $0.46, down 20.7% YoY; reaffirms FY outlook","bullets":["Core net sales $907M, down 3.1% YoY; Core organic net sales down 3.5%.","Core adjusted gross margin 37.0%, down 250 bps; adjusted operating margin 13.0%, down 160 bps.","All In reported diluted EPS $0.63 vs $0.00 prior year, benefiting from Dermacosmetics gain.","Self Care segment net sales down 3.7%; Specialty Care down 2.8%; Infant Formula up 23.1%.","Reaffirmed FY 2026 outlook: Core adj. EPS $2.25-$2.55, Core adj. gross margin 39.0%-40.0%."],"urls":{"canonical":"https://secwatch.observer/filing/0001585364-26-000143","json":"https://secwatch.observer/filing/0001585364-26-000143.json","markdown":"https://secwatch.observer/filing/0001585364-26-000143.md","text":"https://secwatch.observer/filing/0001585364-26-000143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585364/000158536426000143/0001585364-26-000143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585364/000158536426000143/prgo-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T10:40:07.804942+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}